                         SEQUENCE LISTING

<110>  MOR RESEARCH APPLICATIONS
 
<120>  TREM2 ANTIBODIES AND USES THEREOF

<130>  4143.004PC02/GLL/CLD

<150>  US 62/777,613
<151>  2018-12-10

<150>  US 62/789,272
<151>  2019-01-07

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR H1 IMGT

<400>  1

Gly Tyr Thr Phe Thr Asp Tyr Asn 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR H2 IMGT

<400>  2

Ile Tyr Pro Lys Asn Gly Gly Thr 
1               5               


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR H3 IMGT

<400>  3

Ala Arg Arg Thr Ala Arg Ala Ser Trp Phe Ala Phe 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR L1 IMGT

<400>  4

Gln Ser Leu Leu Tyr Ser Ser Asn Gln Lys Asn Tyr 
1               5                   10          


<210>  5
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR L2 IMGT

<400>  5

Trp Ala Ser 
1           


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR L3

<400>  6

Gln Gln Tyr Tyr Asn Tyr Pro Phe Thr 
1               5                   


<210>  7
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  hCGX101 VH

<400>  7

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Asn Ile His Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Tyr Ile Tyr Pro Lys Asn Gly Gly Thr Gly Tyr Thr Gln Lys Phe 
    50                  55                  60                  


Lys Ser Gln Val Thr Ile Ser Val Asp Asn Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Thr Ala Arg Ala Ser Trp Phe Ala Phe Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  8
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  hCGX101 VL

<400>  8

Asp Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Lys Ser Ser Gln Ser Leu Leu Tyr Ser 
            20                  25                  30          


Ser Asn Gln Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Ala Pro Arg Val Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Ile 
    50                  55                  60                  


Pro Ala Arg Phe Ser Gly Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ser Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Asn Tyr Pro Phe Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile 
            100                 105                 110         


Lys 
    


<210>  9
<211>  230
<212>  PRT
<213>  Homo sapiens

<400>  9

Met Glu Pro Leu Arg Leu Leu Ile Leu Leu Phe Val Thr Glu Leu Ser 
1               5                   10                  15      


Gly Ala His Asn Thr Thr Val Phe Gln Gly Val Ala Gly Gln Ser Leu 
            20                  25                  30          


Gln Val Ser Cys Pro Tyr Asp Ser Met Lys His Trp Gly Arg Arg Lys 
        35                  40                  45              


Ala Trp Cys Arg Gln Leu Gly Glu Lys Gly Pro Cys Gln Arg Val Val 
    50                  55                  60                  


Ser Thr His Asn Leu Trp Leu Leu Ser Phe Leu Arg Arg Trp Asn Gly 
65                  70                  75                  80  


Ser Thr Ala Ile Thr Asp Asp Thr Leu Gly Gly Thr Leu Thr Ile Thr 
                85                  90                  95      


Leu Arg Asn Leu Gln Pro His Asp Ala Gly Leu Tyr Gln Cys Gln Ser 
            100                 105                 110         


Leu His Gly Ser Glu Ala Asp Thr Leu Arg Lys Val Leu Val Glu Val 
        115                 120                 125             


Leu Ala Asp Pro Leu Asp His Arg Asp Ala Gly Asp Leu Trp Phe Pro 
    130                 135                 140                 


Gly Glu Ser Glu Ser Phe Glu Asp Ala His Val Glu His Ser Ile Ser 
145                 150                 155                 160 


Arg Ser Leu Leu Glu Gly Glu Ile Pro Phe Pro Pro Thr Ser Ile Leu 
                165                 170                 175     


Leu Leu Leu Ala Cys Ile Phe Leu Ile Lys Ile Leu Ala Ala Ser Ala 
            180                 185                 190         


Leu Trp Ala Ala Ala Trp His Gly Gln Lys Pro Gly Thr His Pro Pro 
        195                 200                 205             


Ser Glu Leu Asp Cys Gly His Asp Pro Gly Tyr Gln Leu Gln Thr Leu 
    210                 215                 220                 


Pro Gly Leu Arg Asp Thr 
225                 230 


<210>  10
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR H1 KABAT

<400>  10

Asp Tyr Asn Ile His 
1               5   


<210>  11
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR H2 KABAT

<400>  11

Tyr Ile Tyr Pro Lys Asn Gly Gly Thr Gly Tyr Thr Gln Lys Phe Lys 
1               5                   10                  15      


Ser 
    


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR H3 KABAT

<400>  12

Arg Thr Ala Arg Ala Ser Trp Phe Ala Phe 
1               5                   10  


<210>  13
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR L1 KABAT

<400>  13

Lys Ser Ser Gln Ser Leu Leu Tyr Ser Ser Asn Gln Lys Asn Tyr Leu 
1               5                   10                  15      


Ala 
    


<210>  14
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CGX101 CDR L2 KABAT

<400>  14

Trp Ala Ser Thr Arg Glu Ser 
1               5           


